Breaking News From Pharma & Bio Ingredients Subscribe via RSS Subscribe via RSS



November 30, 2006



Strong Pipeline Will Power Pfizer


Posted on 2006-11-30 14:06:00



Ligand Initiates Clinical Trials for Thrombocytopenia Drug


Posted on 2006-11-30 14:02:00



Durect Posts Postive Phase I Results for Abuse-Resistant Opioid


Posted on 2006-11-30 13:58:00



PRTX-100 Demonstrates Efficacy against Rheumatoid Arthritis


Posted on 2006-11-30 13:56:00



November 29, 2006



Noven Gets OK to Boost Methylphenidate


Posted on 2006-11-29 10:10:00



Teva Gets OK for Migraine Treatment


Posted on 2006-11-29 10:10:00



Pfizer to Slash Sales Force by 20 Percent


Posted on 2006-11-29 10:08:00



Progen Gets OK to Move Anti-Cancer Drug to Phase III


Posted on 2006-11-29 10:05:00



November 28, 2006



Organon and Pfizer Cancel Bipolar Collaboration


Posted on 2006-11-28 07:39:00



Neurogen In-licenses Aplindore for Phase II Trial


Posted on 2006-11-28 07:37:00



SkyePharma Gets Australian OK for Solaraze


Posted on 2006-11-28 07:35:00



Barr Gets FDA OK for Generic Pravachol


Posted on 2006-11-28 07:34:00



ViRexx To Focus on Near-term Projects


Posted on 2006-11-28 06:40:00



November 27, 2006



Genzyme Begins Leukemia Treatment Trial


Posted on 2006-11-27 17:17:00



Cytokinetics, GlaxoSmithKline Amend Deal


Posted on 2006-11-27 17:16:00



NEWS ARCHIVES

2008

2007

2006

2005

2004

NEWSLETTER SIGNUP